Review





Similar Products

99
Miltenyi Biotec foxp3
Foxp3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
foxp3 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec miltenyi foxp3 buffer set
Miltenyi Foxp3 Buffer Set, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/miltenyi foxp3 buffer set/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
miltenyi foxp3 buffer set - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec foxp3 staining buffer
Foxp3 Staining Buffer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 staining buffer/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
foxp3 staining buffer - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec 2026 set
2026 Set, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2026 set/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
2026 set - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec foxp3 buffer
Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and <t>Foxp3</t> + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.
Foxp3 Buffer, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 buffer/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
foxp3 buffer - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec foxp3 staining buffer set
Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and <t>Foxp3</t> + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.
Foxp3 Staining Buffer Set, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 staining buffer set/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
foxp3 staining buffer set - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec miltenyi 130 093 142
Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and <t>Foxp3</t> + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.
Miltenyi 130 093 142, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/miltenyi 130 093 142/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
miltenyi 130 093 142 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec foxp3 staining buffer kit
Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and <t>Foxp3</t> + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.
Foxp3 Staining Buffer Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxp3 staining buffer kit/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
foxp3 staining buffer kit - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and Foxp3 + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.

Journal: Frontiers in Immunology

Article Title: Prognostic immunological implications of OX40L expression in the tumor microenvironment of melanoma

doi: 10.3389/fimmu.2026.1745742

Figure Lengend Snippet: Cellular phenotyping of OX40L + cells in melanoma tumors. (a) OX40L expression on SOX10 + melanoma cells was manually assessed in 30 tumors (5–10 ROIs per tumor; 3 mm² per ROI). Representative images of membrane-associated OX40L expression and a summary of prevalence across tumors are shown. Rare OX40L + melanoma cells (<10 cells per ROI) were classified as “scattered” or “focally clustered,” whereas “widespread” distribution was defined as OX40L expression in ~10% of SOX10 + melanoma cells per ROI. (b) Exploratory OX40L immune cell phenotyping was performed on serial tumor sections from three melanoma cases. Representative multiplex immunofluorescence images illustrate OX40L expression in macrophages (CD68 + , CD163 + ), dendritic cells (CD11c + ), CD4 + T cells, CD8 + T cells, and Foxp3 + regulatory T cells. (c) Proportions of immune cell subsets within the TME across three tumors (8–15 ROIs per tumor). (d) Violin plots depicting the proportion of OX40L + cells within each immune subset. Mac, macrophages; DC, dendritic cells; T, T cells. Each dot represents one ROI, dot colors represent tumor sample, and mean and median values are shown in red squares and black diamonds.

Article Snippet: Cells were stained with fluorophore-conjugated antibodies against CD4, CD25, OX40, OX40L, and intracellular Foxp3 using the Foxp3 Buffer Set (Miltenyi Biotec, Bergisch Gladbach, Germany).

Techniques: Expressing, Membrane, Multiplex Assay, Immunofluorescence

Expression of OX40L and OX40 on regulatory T cells in melanoma tumors and peripheral blood of a healthy donor. OX40L and OX40 expression were assessed on Foxp3 + regulatory T cells (Tregs) across 30 melanoma tumors using quantitative multiplex immunofluorescence analysis (10–20 ROIs per tumor; 3 mm² per ROI). (a) Representative images showing Foxp3 + Tregs within a melanoma tumor (Foxp3 + nuclei shown in orange when alone or magenta when overlaid with DAPI) co-expressing OX40L (green), OX40 (red), or both. Right panels show higher-magnification views of circled cells with individual color channels; all panels share the same scale bar, indicated in the DAPI image. (b) Box plots depicting the proportions of OX40L + , OX40 + , and double-positive Tregs across 30 tumors. The mean is indicated by a “X” mark and the median by a horizontal line (***p < 0.001, Student’s t-test). Jittered dots represent the mean value per tumor across ROIs. (c) Box plots showing the prevalence of OX40L + (green), OX40 + (red), and OX40L + /OX40L + double-positive (blue) Tregs per tumor, ordered by OX40L + frequency. Jittered dots represent individual ROIs. (d) Tregs isolated from peripheral blood of a healthy donor were enriched and expanded in vitro under IL-2/CD3/CD28 stimulation. The proportions of OX40L + and OX40 + cells within live, singlet Foxp3 + regulatory T cells, as defined in the Methods, are shown over 13 days of culture.

Journal: Frontiers in Immunology

Article Title: Prognostic immunological implications of OX40L expression in the tumor microenvironment of melanoma

doi: 10.3389/fimmu.2026.1745742

Figure Lengend Snippet: Expression of OX40L and OX40 on regulatory T cells in melanoma tumors and peripheral blood of a healthy donor. OX40L and OX40 expression were assessed on Foxp3 + regulatory T cells (Tregs) across 30 melanoma tumors using quantitative multiplex immunofluorescence analysis (10–20 ROIs per tumor; 3 mm² per ROI). (a) Representative images showing Foxp3 + Tregs within a melanoma tumor (Foxp3 + nuclei shown in orange when alone or magenta when overlaid with DAPI) co-expressing OX40L (green), OX40 (red), or both. Right panels show higher-magnification views of circled cells with individual color channels; all panels share the same scale bar, indicated in the DAPI image. (b) Box plots depicting the proportions of OX40L + , OX40 + , and double-positive Tregs across 30 tumors. The mean is indicated by a “X” mark and the median by a horizontal line (***p < 0.001, Student’s t-test). Jittered dots represent the mean value per tumor across ROIs. (c) Box plots showing the prevalence of OX40L + (green), OX40 + (red), and OX40L + /OX40L + double-positive (blue) Tregs per tumor, ordered by OX40L + frequency. Jittered dots represent individual ROIs. (d) Tregs isolated from peripheral blood of a healthy donor were enriched and expanded in vitro under IL-2/CD3/CD28 stimulation. The proportions of OX40L + and OX40 + cells within live, singlet Foxp3 + regulatory T cells, as defined in the Methods, are shown over 13 days of culture.

Article Snippet: Cells were stained with fluorophore-conjugated antibodies against CD4, CD25, OX40, OX40L, and intracellular Foxp3 using the Foxp3 Buffer Set (Miltenyi Biotec, Bergisch Gladbach, Germany).

Techniques: Expressing, Multiplex Assay, Immunofluorescence, Isolation, In Vitro